![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_951390f3ca47108161f98c39fe1fa469.svg) | Talnetant | Ki | 144.0 [1], 3700.0 [2], 3981.07 [3], 10000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a49b43e6ef8b8b8254a671fc6550a55a.svg) | (2S,5S,8R)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f4c3d18ad43aa0f0221d225052d1b178.svg) | Neurokinin A | IC50 | 1.7 [1], 7.7 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f4c3d18ad43aa0f0221d225052d1b178.svg) | Neurokinin A | Ki | 0.71 [1], 1.2 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_be2f56dbc029d0ee9a4717d51c2f107f.svg) | Saredutant | IC50 | 0.13 [1], 0.44 [2], 0.8 [3] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_be2f56dbc029d0ee9a4717d51c2f107f.svg) | Saredutant | Ki | 0.5 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_6791ef48b920d1f0f981df911718d1d0.svg) | Osanetant | Ki | 35.5 [1], 40.3 [2], 79.43 [3], 85.0 [4] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_7bb5747002099865ee48f8a15ae88572.svg) | 1-[(4Z)-5-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-3-(3,4-dichlorophenyl)-4-methoxyiminopentyl]-4-phenylpiperidin-4-ol | Ki | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_1224299eee4ddfb1365a14806040768a.svg) | Neurokinin B | IC50 | 102.33 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_1224299eee4ddfb1365a14806040768a.svg) | Neurokinin B | Ki | 15.85 [1], 42.2 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_ea20c46a46ce5792c3f351371fad74d3.svg) | Neurokinin A (4-10), nle(10)- | IC50 | 2.5 [1], 3.5 [2], 9.2 [3] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f645ce20acf304050876e87676259866.svg) | (2S,5S,8R)-5-Benzyl-8-[(3,4-dichlorophenyl)methyl]-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 0.1 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f1437549f1ad860327adaf30cd5ef856.svg) | 3-((E)-3-Carboxy-3-phenyl-allyl)-4,6-dichloro-1H-indole-2-carboxylic acid | IC50 | 8.0 [1], 8.4 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f1437549f1ad860327adaf30cd5ef856.svg) | 3-((E)-3-Carboxy-3-phenyl-allyl)-4,6-dichloro-1H-indole-2-carboxylic acid | Ki | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_1b26bb07fe0a9d29955bfffe2eeb916c.svg) | Substance P | IC50 | 245.47 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_1b26bb07fe0a9d29955bfffe2eeb916c.svg) | Substance P | Ki | 102.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_11700ec0bbbcc9e2423cdcf74d94904c.svg) | Senktide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_11700ec0bbbcc9e2423cdcf74d94904c.svg) | Senktide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_d829a55609164985920ed3e6b9db6f9b.svg) | 3,5-Bis(trifluoromethyl)benzyl N-acetyltryptophan | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_d1e83215bb3f43d07eeacadac34ea393.svg) | SB 218795 | Ki | 1221.0 [1], 8333.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_ab6e401e9183b5579fc0d5d6d56446f1.svg) | Unii-G9BL4978MZ | IC50 | 5.5 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_ab6e401e9183b5579fc0d5d6d56446f1.svg) | Unii-G9BL4978MZ | Ki | 9.55 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_cf01561e1f8ab03bdef4b79d31f34ec1.svg) | Serlopitant | IC50 | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_cf01561e1f8ab03bdef4b79d31f34ec1.svg) | Serlopitant | Ki | 2.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_606de720b0934b85c5c83556314474b7.svg) | CID 9852253 | Ki | 0.6 [1], 0.64 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_95e35a36eadcd48026b35e062cd316d6.svg) | Phenyl-[(2-phenyl-quinoline-4-carbonyl)-amino]-acetic acid methyl ester | Ki | 2947.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_bed15c3bc032db6ec814e6c900040213.svg) | (MePhe7)neurokinin B | Ki | 1597.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_fd3722483f37a0fcce5f03da7158247b.svg) | Methyl (2R)-2-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]acetate | Ki | 1221.0 [1], 8333.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_79ab15967e95ffffaeb79c87f6ead8ae.svg) | N-[(E,2R)-1-(4-Chlorophenyl)-5-oxo-5-[[(3R)-2-oxoazepan-3-yl]amino]pent-3-en-2-yl]-N-methyl-3,5-bis(trifluoromethyl)benzamide | IC50 | 24.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_bf8a98ced789e2a02adfcee7b8a5bd35.svg) | N-[1-[[(2R)-1-(3-Morpholin-4-ylpropylamino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide | Ki | 0.63 [1], 0.66 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_d9676f86303e63c6020e7190bae10df5.svg) | (2S,5S,8R,12R)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-12-morpholin-4-yl-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 0.16 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_aa619b7a71a967456bc0d99cd0148d8b.svg) | (3,5-Dimethylphenyl)methyl (2S)-3-(1H-indol-3-yl)-2-(methylcarbamoylamino)propanoate | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a980a8f5611f83e5ce368d013ffea220.svg) | (2S,5S)-2-(1H-Indole-3-ylmethyl)-5-benzyl-1,4,7,10-tetraazacyclotetradecane-3,6,11,14-tetrone | Ki | 1258.93 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_eb8b46b9d9a001d396c9f5c6e7f95e16.svg) | (2S,5S)-5,12-Dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 794.33 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_57e0b6e3033e76428063e1c6a264d7c0.svg) | (2S,5S,8R)-5-Benzyl-8-(cyclohexylmethyl)-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 316.23 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_0a513e2b85ef3026ef94226bcdbc0cee.svg) | (2S,5S,8R)-5-Benzyl-2-(1H-indol-3-ylmethyl)-8-(naphthalen-2-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 7.94 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_643d3461a8fd6a1383df2b49e344b928.svg) | (2S,5S,8R)-5-Benzyl-8-[(3,4-difluorophenyl)methyl]-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 1.58 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_835fd6054168382c3b996ddf9a8791ab.svg) | (2S,5S,8R,12S)-12-Amino-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 3.16 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_430b3fa140ccd4a41be65b4fa9fc25ef.svg) | N-[(2S,5S,8R,12R)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-3,6,11,14-tetraoxo-1,4,7,10-tetrazacyclotetradec-12-yl]-2-morpholin-4-ylacetamide | Ki | 0.32 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_c6509e384feec057e4a2f1f9a6a40a8a.svg) | (2S,5S,8R,13S)-13-Amino-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 3.16 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_e101f273b601a0e1897cf77bb0633f46.svg) | N-[2-(4-Chlorophenyl)-5-(cyclohexylcarbamoyl)phenyl]-3,4,5-trimethoxybenzamide | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_6d409537a9e8dde90669a21df8f70b39.svg) | 4-(4-Methylphenyl)-N-[1-[[(2R)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]benzamide | Ki | 0.32 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_594beb93b9a7c157a1ad71951753c98d.svg) | [(8R)-8-Methyl-3-(2-methyl-1,3-thiazol-4-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-(4-thiophen-2-ylphenyl)methanone | Ki | 12589.25 [1], 14000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_ca23c859acde093a8bc7f26bd2da791b.svg) | N-[4-(4-Acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide | IC50 | 8.9 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_ca23c859acde093a8bc7f26bd2da791b.svg) | N-[4-(4-Acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide | Ki | 0.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_8084cb08afe6689edafea5243cac3e2e.svg) | (2S,5S,8R,12S)-5,8-Dibenzyl-2-(1H-indol-3-ylmethyl)-12-morpholin-4-yl-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone | Ki | 0.79 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a6969fead14f54e16600a9ea542ec26b.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 30.9 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a6969fead14f54e16600a9ea542ec26b.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 12.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a9092b00c33359888a19aba67f6e7807.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 107.15 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a9092b00c33359888a19aba67f6e7807.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 44.2 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_9bb501fdbcef398f5f97bd8f032e4f98.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-aminophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 371.54 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_9bb501fdbcef398f5f97bd8f032e4f98.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-aminophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 156.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_2b3c1379d304ca821fe75dc97655bbfe.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-chlorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | IC50 | 3467.37 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_2b3c1379d304ca821fe75dc97655bbfe.svg) | (3S)-3-Amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-5-methyl-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-chlorophenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | Ki | 1422.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_71acea9a6dfc0e4dac7865946b73384c.svg) | Paclitaxel | Ki | 2042.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_beb7f72e73f61c5a9e1bf58b6572d39a.svg) | Cyclosporin A | Ki | 1380.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f28ce47318433f5c984060ce11c4a797.svg) | Tamoxifen | Ki | 1223.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a7e11d7bcee94c9af8c42c557a082c25.svg) | Chlorpromazine | Ki | 9065.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_81af8877c0a8c32165f86d729092ee41.svg) | Amiodarone | Ki | 6438.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_01ae8b9629ab2f1b394fdd8173a950dd.svg) | Docetaxel | Ki | 521.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a69f1db31ed30d6a63db389cb16202f2.svg) | Ketoconazole | Ki | 5748.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_adf25e33d7987b11abe6dedf76999efd.svg) | Diethylstilbestrol | Ki | 3184.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_9eea3482ccbd85339d3c08d99095be33.svg) | Ritonavir | Ki | 874.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_eeee657d685332dfcad1bdbf13f04b70.svg) | Lovastatin | Ki | 9408.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_61ac18529dc29ce93ca24de10a3f2090.svg) | Raloxifene | Ki | 1330.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_99788722e9cae05cd98a370a50e594a1.svg) | Vinorelbine | Ki | 535.55 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_3cb028e31ae7d8478d6b470183cabec1.svg) | Clomiphene | Ki | 1508.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_c9960c7f038fe75af1672de453506a31.svg) | Indinavir | Ki | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f6243f25305675c28e917d742a66bc50.svg) | Danazol | Ki | 8860.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_b4f76a216efed394b41035ecb49dec98.svg) | Miconazole | Ki | 1613.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_6c5a78e8ca55529a3f6c3b506ecb26d6.svg) | Clotrimazole | Ki | 3383.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_9c3e8c98f84d2db0794a5dead5c845db.svg) | Saquinavir | Ki | 2071.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_601c33238027d88f839c5e4fc21f3344.svg) | Nelfinavir | Ki | 9793.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_53e0258413dfe8503285a6d017480c2b.svg) | Fluphenazine | Ki | 7495.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_19f8e8cc27453da48f6dcd3cdac21a9f.svg) | Gentian violet | Ki | 560.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_79b99809a4327da541aa2304e553f873.svg) | Terfenadine | Ki | 892.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_c8f776821da2b81ebb31d68f47ca25d7.svg) | Montelukast | Ki | 1274.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_fc46558a34b8c1954e8bb3558c58f6f2.svg) | Hexachlorophene | Ki | 1379.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_027bfc4e5cd37289c12839b3b448957d.svg) | 4-Nonylphenol | Ki | 1505.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_86d29e4d2a023444168a1151479dc8d3.svg) | alpha-Naphthoflavone | Ki | 1949.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f67d9004e24bf13185c0a0543b060ab0.svg) | Astemizole | Ki | 995.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_0e06682e28b9fadd6faa1c46a98e31f5.svg) | Econazole | Ki | 2011.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a53e638f4a9d59bfab2ef3263004ccf8.svg) | Metergoline | Ki | 1357.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_fdb3c6f7e3716bf6374587a2f2bb3d3e.svg) | 4-Octylphenol | Ki | 5810.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_b70f3c1aff22b2c3012558f15a129086.svg) | Ciglitazone | Ki | 4192.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_e8ce48cfb2f6a869653fc4c030f1fb78.svg) | 2-(Diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo(2.2.2)octan-3-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_ddea5339ebd2113aa6ec148dcd1aad53.svg) | Ebastine | Ki | 644.3 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_b0179281692ca8e37a5d8c47f5c60c93.svg) | Benzethonium chloride | Ki | 642.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_5a5b2db7898174efe1b0850be1ba01e3.svg) | Bithionol | Ki | 1553.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_25f9accc96aecaa36a0245d917c0bb99.svg) | (1S,2R)-2-(Octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol | Ki | 2264.3 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_2e36dd5b26a89e0d11ad6414b9f95735.svg) | Sulconazole | Ki | 1653.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_66b4b3fc1f2c32238892c82fbcafbc0a.svg) | (S)-2-(2-Benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid | Ki | 4836.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_1363fd4469860fc83738677f44fc8897.svg) | Oxiconazole | Ki | 1073.9 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_1373b1a981fb8d01187c7c24c4d89f64.svg) | 3-((3,5-Bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidine | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_5e2a6e001b69f543fa948a34d23ce8fa.svg) | 3-Methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide | Ki | 277.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_718681422ca21a5e110a7996f2e906e1.svg) | CID 6918468 | IC50 | 87.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_a2afa4f2eebd5049e2069b51cd4a67b7.svg) | Haloprogin | Ki | 491.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_0c92c9c64d7d83aeabbf1ca07d62fdf5.svg) | (1S,4S,7S,10S,13S,16S)-4-Benzyl-7-(1H-indol-3-ylmethyl)-16-(2-methylpropyl)-13-(2-methylsulfanylethyl)-2,5,8,11,14,17,20-heptazabicyclo[8.8.4]docosane-3,6,9,12,15,18,21-heptone | Ki | 0.63 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_f6de6c25d9ac49e91bd58ff1d73ba49f.svg) | Propan-2-yl (2S)-2-[[(2S)-2-[(2S,3S)-2-[[(2R)-2-amino-3-sulfanylpropyl]amino]-3-methylpentoxy]-3-phenylpropanoyl]amino]-4-methylsulfonylbutanoate | Ki | 536.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurokinin-2-receptor_03966a579806c0944c8470308f706045.svg) | Cetylpyridinium bromide | Ki | 2877.0 [1] |